Homepage

Pasithea Therapeutics Corp.

KTTA NASDAQ Categories PDF
Healthcare · Biotechnology · United States · Updated May 10, 6:12pm
$0.80
Price
$5.9M
Market Cap
4
Employees
0.22
Beta
Tiago Reis Marques
CEO
Business Description

Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.

Business History
Price Overview
Last updated: May 11, 2026 1:57pm (just now)
$0.80
0.00 (-0.03%)
Day Range
$0.76 – $0.80
52-Week Range
$0.28 – $2.06
50-Day MA
$0.77
200-Day MA
$0.81
Volume
59,471.16
Analyst Price Targets
Low $3.00
Consensus $3.00
High $3.00
(1 analysts)
Share Structure
Outstanding 7,442,153.00
Float 7,319,865.00
Free Float 98.4%
High free float — 98.4% of shares trade freely, ~1.6% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Small absolute float (7.3M shares) — even with a decent free float %, volume can be thin. Check average daily volume before sizing a position.
Price History (1 Year)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-0.27
Stock Price: $0.80
EPS (Diluted): -2.91
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
0.16
Stock Price: $0.80
Total Equity: $55.22M
Shares: 7,031,000
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
2.45
Market Cap: $5.92M
Total Debt: $0.00
Cash: $55.16M
EBITDA: -$20.19M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
-$46.1M
Market Cap: $5.92M
Total Debt: $0.00
Cash: $55.16M
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
0.0%
Gross Profit: $0.00
Revenue: $0.00
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
0.0%
Operating Income: -$20.86M
Revenue: $0.00
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
0.0%
Net Income: -$20.43M
Revenue: $0.00
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-85.5%
Net Income: -$20.43M
Total Equity: $55.22M
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-37.7%
Operating Income: -$20.86M
Tax Rate: 0.0%
Equity: $55.22M
Total Debt: $0.00
Cash: $55.16M
Zero debt — invested capital = equity minus cash (very efficient)
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
11.35
Current Assets: $56.46M
Current Liabilities: $4.97M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.00
Short-Term Debt: $0.00
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $55.22M
Zero debt — this company carries no debt obligations. Strongest possible score.
Rev/Share (Top-line per share)
Revenue / Shares Outstanding
—
Revenue: $0.00
Shares: 7,031,000
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$7.85
Total Equity: $55.22M
Shares: 7,031,000
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-2,163.49
Operating CF: -$15.21B
CapEx: $0.00
Shares: 7,031,000
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $0.80
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: -$20.43M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares KTTA against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Metric 2021 2022 2023 2024 2025
Revenue $15,062 $0 $0 $0 $0
Cost of Revenue $17,275 $5,094 $0 $0 $0
Gross Profit $-2,213 $-5,094 $0 $0 $0
Operating Expenses $4.5M $12.6M $16.0M $14.2M $20.9M
Operating Income -$4.5M -$12.6M -$16.0M -$14.2M -$20.9M
Net Income -$2.2M -$13.9M -$16.0M -$13.9M -$20.4M
EBITDA -$4.5M -$11.7M -$15.3M -$13.6M -$20.2M
EPS $-1.89 $-10.34 $-12.65 $-12.69 $-2.91
EPS (Diluted) — — — — —
Balance Sheet (Annual)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $53.0M $33.1M $16.3M $6.9M $55.2M
Total Current Assets $53.3M $34.1M $16.7M $7.4M $56.5M
Total Assets $53.3M $45.2M $26.1M $16.1M $60.2M
Current Liabilities $447,280 $1.9M $2.6M $1.1M $5.0M
Long-Term Debt $0 $0 $0 $0 $0
Total Liabilities $1.9M $2.7M $2.7M $1.3M $5.0M
Total Equity $51.4M $42.5M $23.4M $14.8M $55.2M
Retained Earnings -$2.2M -$19.4M -$35.3M -$49.6M -$70.0M
Cash Flow (Annual)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$3.2M -$13.7M -$13.4M -$13.9M -$15.2B
Capital Expenditure $-21,503 $-107,102 $-34,301 $-2 $0
Free Cash Flow -$3.2M -$13.8M -$13.5M -$13.9M -$15.2B
Acquisitions (net) $0 -$2.2M $0 $0 $0
Debt Repayment — — — — —
Dividends Paid — — — — —
Stock Buybacks $0 $0 -$3.7M $0 $0
Net Change in Cash $52.7M -$19.9M -$16.8M -$9.4M $48.3B
Analyst Estimates (Annual)
Metric 2025 2026 2027 2028
Revenue $0 $0 $0 $0
EBITDA $0 $0 $0 $0
Net Income -$10.5M
-$10.5M – -$10.5M
 -$13.1M
-$13.1M – -$13.1M
 -$14.8M
-$14.8M – -$14.8M
 -$16.2M
-$16.2M – -$16.2M
EPS — — — —
Growth Trends (YoY %)
Metric 2022 2023 2024 2025
Revenue Growth -100.0% — — —
Gross Profit Growth -130.2% +100.0% — —
Operating Income Growth -179.3% -26.9% +10.8% -46.4%
Net Income Growth -541.2% -14.5% +12.9% -46.9%
EBITDA Growth -160.2% -30.8% +11.3% -48.5%
Insider Trading (Recent)
Date Insider Type Shares Price Value
2026-05-01 Marques Tiago A-Award 1,756,069.00 $0.84 $1.5M
2026-05-01 STEINMAN LAWRENCE A-Award 152,783.00 $0.84 $128,491
2026-05-01 Dumesnil Simon A-Award 152,783.00 $0.84 $128,491
2026-05-01 Schneiderman Daniel H A-Award 1,129,323.00 $0.84 $949,761
2026-05-01 Krishnan Kartik A-Award 1,129,323.00 $0.84 $949,761
2026-05-01 Leahy Emer A-Award 152,783.00 $0.84 $128,491
2026-05-01 Novak Alfred J A-Award 152,783.00 $0.84 $128,491
2026-05-01 Krishnan Kartik 0.00 $0.00 $0
2026-04-09 Coastlands Capital LP 0.00 $0.00 $0
2026-04-09 Coastlands Capital LP 11,233,334.00 $0.00 $11,233
2025-11-28 STEINMAN LAWRENCE P-Purchase 133,333.00 $0.75 $100,000
2025-11-28 Schneiderman Daniel H A-Award 26,667.00 $0.75 $20,000
2025-11-28 Marques Tiago P-Purchase 33,333.00 $0.75 $25,000
2025-11-28 Dumesnil Simon P-Purchase 33,333.00 $0.75 $25,000
2025-11-28 Leahy Emer A-Award 33,333.00 $0.75 $25,000
2025-10-24 STEINMAN LAWRENCE A-Award 242,913.00 $0.72 $173,683
2025-10-24 Schneiderman Daniel H A-Award 317,266.00 $0.72 $226,845
2025-10-24 Novak Alfred J A-Award 42,913.00 $0.72 $30,683
2025-10-24 Marques Tiago A-Award 493,341.00 $0.72 $352,739
2025-10-24 Leahy Emer A-Award 42,913.00 $0.72 $30,683
Community AI Feedback
Sign in to Contribute
No community reviews yet for KTTA. Be the first — export the analysis to your AI and contribute back.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.193 · 1946f027 · 2026-05-08 18:57:27